6H-Benzo[c]chromen-6-one derivatives as selective ERβ agonists
Wanying SunDepartment of Medicinal Chemistry, Merck Research Laboratories, PO Box 2000, Rahway, NJ 07065, USA. [email protected]L. D. CamaDepartment of Medicinal Chemistry, Merck Research Laboratories, PO Box 2000 Rahway, NJ 07065, USAElizabeth T. BirzinDepartment of Atherosclerosis and Endocrinology, Merck Research Laboratories, PO Box 2000 Rahway, NJ 07065, USASudha WarrierDepartment of Atherosclerosis and Endocrinology, Merck Research Laboratories, PO Box 2000 Rahway, NJ 07065, USALouis LoccoDepartment of Atherosclerosis and Endocrinology, Merck Research Laboratories, PO Box 2000 Rahway, NJ 07065, USARalph MosleyDepartment of Medicinal Chemistry, Merck Research Laboratories, PO Box 2000 Rahway, NJ 07065, USAMilton L. HammondDepartment of Medicinal Chemistry, Merck Research Laboratories, PO Box 2000 Rahway, NJ 07065, USASusan P. RohrerDepartment of Atherosclerosis and Endocrinology, Merck Research Laboratories, PO Box 2000 Rahway, NJ 07065, USA
2006en
ABI
Аннотация
Аннотация мавжуд эмас.
Идентификаторлар
Иқтибослар ва манбалар
3 та иқтибос0 та фойдаланилган манба